Press-release for stocks publishing date 2021 - 08

Prices are updated after-hours

publishing date : 2021 - 08 - 02 source : Www.biospace.com

save search

Eledon Pharmaceuticals to Release Second Quarter Financial Results on Thursday, August 12, 2021Management to host conference call and webcast at 4:30 pm ET
Published: 2021-08-02 (Crawled : 23:00) - biospace.com/
ELDN | $1.97 16K

Manufacturing

| -69.65% | O: 1.08% H: 2.29% C: 1.68%
financial results results conference

Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.46 -0.72% 820K

Health Technology

| -14.09% | O: 0.02% H: 0.21% C: -0.12%

Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
ICVX | $15.31 -0.65% 9.3M

| -38.23% | O: 1.01% H: 7.81% C: 3.35%
offering

Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
NVO | News | $124.46 -1.35% 730K

Health Technology

| 36.24% | O: -0.44% H: 0.89% C: 0.88%
LLY | News | $724.615 -1.04% 480K

Health Technology

| 207.41% | O: 0.43% H: 0.88% C: 0.35%
ALNY | $142.22 -1.1% 25K

Health Technology

| -20.81% | O: -1.81% H: 0.94% C: -0.19%
financial results results

GSK files for licensure of MMR vaccine in the US
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
GSK | News | $40.93 0.17% 170K

Health Technology

| 1.97% | O: -0.37% H: 0.98% C: 0.8%
vaccine

Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
GOSS 4 | $0.7083 28K

Health Technology

| -90.97% | O: 0.13% H: 1.65% C: -2.54%
financial results results conference

Mereo BioPharma to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RARE F | $43.44 -1.9% 41K

Health Technology

| -44.53% | O: 0.16% H: 2.6% C: 1.1%
MREO | $2.685 -3.42% 91K

Health Technology

| 8.17% | O: 0.0% H: 4.47% C: 2.72%
biopharma biotech technology iot conference

Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9th
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
PGEN | $1.38 -2.82% 92K

Health Technology

| -74.13% | O: 0.36% H: 3.54% C: 1.81%
financial results results

REGENXBIO to Host Conference Call on August 9 to Discuss Second Quarter 2021 Financial Results and Recent Operational Highlights
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RGNX | $15.555 -3.02% 50K

Health Technology

| -50.37% | O: 0.34% H: 3.48% C: -1.45%
financial results results conference

Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
PSNL | $1.215 -6.54% 64K

Health Technology

| -93.81% | O: 0.62% H: 0.71% C: -1.47%
immunotherapy therapy cancer biomarkers

Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RLYB | News | $1.6 1.27% 51K

| -90.71% | O: -2.88% H: 15.08% C: 9.02%
offering

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
CRVS | $1.51 12K

Health Technology

| -27.75% | O: -1.44% H: 7.28% C: 3.88%
financial results results

Prometheus Biosciences Announces Initiation of APOLLO-CD Phase 2a Clinical Trial of PRA023 in Moderate-to-Severe Crohn’s Disease
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RXDX | $199.92 0.02% 1.9M

Professional, Scientific, and T...

| 853.36% | O: 0.62% H: 1.9% C: 1.66%
disease phase 2 trial phase 2b

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring mRNA Vaccine Technology to Vietnam
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
ARCT 4 | $25.6 -5.12% 26K

Health Technology

| -12.94% | O: 6.36% H: 9.92% C: 5.16%
sales collaboration vaccine technology

Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events
Published: 2021-08-02 (Crawled : 17:00) - biospace.com/
NVS | News | $98.67 0.33% 260K

Health Technology

| 6.06% | O: -0.33% H: 0.15% C: -0.16%
IONS | $42.195 -0.6% 99K

Health Technology

| 14.3% | O: 0.24% H: 2.2% C: 1.07%
cardiovascular cardio trial enroll

Kantara Approves LexisNexis® Risk Solutions Risk Defense Platform Compliance with NIST SP 800-63 rev.3 (Technical) Class of Approval, as a Component Service at IAL2
Published: 2021-08-02 (Crawled : 17:00) - biospace.com/
RELX | $40.43 -2.41% 230K

Commercial Services

| 39.82% | O: -0.98% H: 1.09% C: 0.51%
defense risk approval

AbbVie Enjoys Strong Second Quarter as Rinvoq Gears Up to Succeed Humira
Published: 2021-08-02 (Crawled : 15:15) - biospace.com/
ABBV | News | $166.41 -0.83% 860K

Health Technology

| 41.0% | O: -1.78% H: 0.3% C: -1.23%